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SYSTEMATIC REVIEW Open Access
Occurrence, Risk Factors, Prognosis
and Prevention of Swimming-Induced
Pulmonary Oedema: a Systematic Review
Sarah Spencer1* , John Dickinson2 and Lindsay Forbes1
Abstract
Background: Swimming-induced pulmonary oedema (SIPE) can affect people with no underlying health problems,
but may be life threatening and is poorly understood. The aim of this systematic review was to synthesise the
evidence on SIPE incidence, prevalence, risk factors, short- and long-term outcomes, recurrence and effectiveness of
interventions to prevent recurrences.
Methods: We carried out a literature search using bibliographic databases and reference lists. Risk of bias was
assessed by adapting existing quality assessment tools including those developed by the National Heart Lung
and Blood Institute.
Results: Nine studies met the inclusion criteria. Quantitative synthesis was not possible because of study heterogeneity.
Five studies, which differed from each other in case definition, swimming environment, population characteristics and
denominators, reported an incidence of 0.01% of UK triathlons raced over 5 years in unspecified swimming environments
(one study, not fully reported, of men and women of unspecified age); 0.5% of river races swum over 3 days in Sweden
(one study, of men and women up to the age of 70); and 1.8–26.7% of time trials in the sea around Israel (three studies
of male teenage military trainees). One study reported that 1.4% of triathletes in the USA had experienced SIPE. One
study found that hypertension, female sex, fish oil use, long course distance and another lower initial lung volumes and
flows were risk factors for SIPE. A third study reported that higher mean pulmonary artery pressures and pulmonary artery
wedge pressures, and lower tidal volumes were associated with SIPE. Three studies suggested that SIPE symptoms usually
resolve within 24 h, although a restrictive deficit in lung function persisted for a week in one small study. We found no
studies that reported deaths from SIPE. The single small study of longer-term outcomes reported no difference between
affected and unaffected swimmers. Two studies suggested that around 30% of people report recurrences of SIPE. Two
very small uncontrolled studies of the effect of sildenafil for recurrence prevention were inconclusive.
Conclusions: SIPE may be an important public health problem affecting the growing number of recreational open water
swimmers. Further research should clarify the frequency of SIPE among recreational open water swimmers, confirm
reported risk factors and explore others, explore long-term consequences and test interventions to prevent recurrences.
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Key Points
 SIPE occurs when fluid accumulates in the lungs in
the absence of water aspiration during swimming,
causing acute shortness of breath and a cough
productive of blood-tinged sputum.
 SIPE is likely to be a significant public health problem
for open water endurance swimmers and current
estimates of incidence and prevalence may be
underestimates.
 High blood pressure, female sex, fish oil use, long
course distance and smaller lung capacity and flows
may increase risk of SIPE, although these findings
need to be replicated in other studies.
 Evidence on SIPE prognosis and prevention is very
limited, although it seems that most people recover
quickly if removed from the water, and recurrence is
common.
Background
Open water swimming is a popular sport, with 842,500
participants in England in 2016 [1]. However, there is
growing evidence that it is associated with a condition
known as swimming-induced pulmonary oedema (SIPE).
SIPE is a type of immersion pulmonary oedema (IPE)
that occurs when fluid accumulates in the lungs in the
absence of water aspiration during surface or underwater
swimming, causing acute shortness of breath and a
cough productive of blood-tinged sputum [2]. IPE may
affect people with no underlying health problems. It is
thought that in most cases symptoms subside once the
individual leaves the water; however, IPE is potentially
life threatening whilst a swimmer remains immersed and
some IPE deaths in divers have been documented [3].
The risk of death is unknown due to difficulties differen-
tiating between IPE and drowning for other reasons [4]
and the number of cases requiring hospital treatment is
unclear due to the absence of an International Classifica-
tion for Diseases (ICD) diagnosis code.
IPE was first documented in scuba divers in 1981 [5];
however, there is still a lack of understanding of its
occurrence, risk factors, prognosis and preventative
treatments, especially in open water swimmers. IPE oc-
curs when immersion in water creates an extrinsic pres-
sure on the body which can force blood away from the
extremities into the chest. This causes an increase in
pressure gradients across pulmonary capillaries which
can eventually cause a leakage of fluid into the air spaces
in the lung. There is some debate around whether the
different forms of IPE that occur in swimmers, scuba
divers and breath-hold divers should be considered
separately. Davis [6] argued that because the patho-
physiological processes are the same whatever the cir-
cumstances, they should be all be termed immersion
pulmonary oedema. However, Edmonds [7] believed the
three should be separated due to the “considerable dif-
ferences in the epidemiology, aquatic behaviour and
physical stressors in each of these three groups”. He
argued that the circumstances of an elite swimmer/tri-
athlete swimming at the surface and breathing air are
very different from a heavily equipped unfit elderly scuba
diver under high hyperbaric pressures with the potential
exposure to gas toxicity. Breath-hold divers are uniquely
affected by a high ambient pressure on the lungs which
can cause damage known as pulmonary barotrauma or
lung squeeze [8]. For these reasons, we decided to
restrict this review to studies of SIPE in surface
swimmers.
The aim of this systematic review was to synthesise the
epidemiological evidence about SIPE in open water swim-
mers to inform advice on risk of SIPE, implications of the
diagnosis and prevention of episodes and recurrences.
The following research questions were addressed:
1. What is the incidence of SIPE?
2. What is the prevalence of having experienced SIPE?
3. What are the risk factors for SIPE?
4. What are the short-term outcomes of SIPE, i.e.
hospitalisation, death, recovery?
5. What is the recurrence rate of SIPE?
6. What are the long-term health sequelae of an
episode of SIPE?
7. What is the evidence of the effectiveness of
interventions for preventing a recurrence of SIPE?
Methods
Search Strategy
Peer-reviewed publications and conference abstracts were
identified through online searches of the MEDLINE,
EMBASE and HMIC databases using Ovid online up to
April 2018 (see Additional file 1 for search strategy). Add-
itional relevant studies were sought through The Rubicon
Foundation,1 Mendeley, EThOS and reference lists of re-
view papers.
Study Selection Criteria
We included original articles and conference abstracts
(where there was no full paper reporting the same data)
studying human subjects that provided data to answer one
or more of the research questions. Conference abstracts
were included due to the small number of relevant full
text articles. Initially, all abstracts that mentioned IPE
were sought. These were then screened to remove articles
that were not relevant. For the remaining studies, full text
articles, where available, were sought. We then assessed
these articles and abstracts according to the inclusion cri-
teria shown in Additional file 2. The process was carried
out independently by two reviewers.
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Data Extraction and Assessment of Study Quality
Data were extracted by both reviewers independently,
using data extraction forms shown in Additional file 3.
Risk of bias was assessed by adapting quality assessment
tools developed by the National Heart Lung and Blood
Institute [9], Hoy et al. [10] and Downs and Black [11]
(see Additional file 4). Any disagreements were resolved
through discussions and further reviews of studies.
Results
The search strategy identified a total of 353 titles and
abstracts after duplicates were removed, of which 173
were relevant. Initial inclusion criteria were applied to
these records, which included 138 full-text articles and
35 abstracts/titles, which resulted in the exclusion of 162
studies. Of the remaining 11 studies, 9 met the inclusion
criteria for individual research questions (see Fig. 1).
What Is the Incidence of SIPE?
Description of Studies
Five prospective incidence studies met the inclusion cri-
teria; three of male Israeli military trainees aged 18–19
carrying out 2.4–3.6 km swimming time trials in the
open-sea [12–14], one of competitors of 1–3 km swim-
ming races in a Swedish river [15] and one of triathletes
competing in UK triathlons with a 0.4–1.5 km swim [16]
(see Table 1). The military trainee swimming trial studies
took place over a period of 3 years, 2 months and 1 day
respectively [12–14]. Braman Eriksson et al. [15] carried
out their study over 3 days at the Vansbrosimningen
2016 swimming event. Smith et al. [16] studied the com-
petitors of 11 UK triathlon races that took place over
5 years. Sample sizes of included studies ranged from 30
[14] to over 68,000 [15]. Two additional studies of divers
were excluded as they did not meet the inclusion cri-
teria; one of rebreather2 incidents in French military
divers [17] and one of Basic Underwater Demolition/
SEAL trainees at US dive training facilities [18].
Definition of SIPE
The studies used varying case definitions for SIPE apart
from Braman Eriksson et al. [15] who relied on examin-
ing physicians to identify cases without a formal case
definition (M Hardstedt 2018, personal communication,
13 March). These definitions of SIPE are described in
Table 1. In all studies, cases of SIPE were identified from
swimmers that sought medical attention, apart from
Shupak et al. [13] who required all trainees, symptomatic
or not, to complete post-swim questionnaires. They
categorised cases into mild cases where the swimmer
was able to complete the swim and severe cases where
the swim had to be stopped. Different methods were
Fig. 1 PRISMA flow diagram. PRISMA preferred reporting items for systematic reviews and meta-analyses; PE pulmonary edema; IPE immersion
pulmonary oedema. 1 One case report was included in the interventions section due to a lack of relevant studies. 2 Numbers do not add up to
total due to studies that addressed more than one research question
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Table 1 Incidence of SIPE
References Study
design
Subjects Sample size and
description




(n = SIPE cases)
Critical evaluation







Triathletes 68,557 competitors in 11
triathlon races in the UK
between 2011 and 2016,
distances of 400 m, 750 m
and 1500 m
Not reported Absence of water aspiration,
acute onset of dyspnoea, cough
and/or frothy sputum, with evidence







0.01% (n = 5) of
triathlons raced
Conference abstract so




Unclear if any cases were












males, 7561 females) aged
12–70 competing in Swedish
river races over 3 days in







No standard definition. Examining
physicians identified cases without







(n = 69) of races
swum
Patient symptoms and
clinical findings were not
recorded. No information










Unknown number of males
aged 18–19 in swimming
trials of 2.4–3.6 km distance
(average of 30–45 min
duration) in 1998–2001
Open sea of varying
temperatures (19.6 °C
± 3.2), no wetsuits,
supine semi-reclining
position with fins
Severe shortness of breath and
coughing during or after swimming
in the absence of sea aspiration, and








1.8% (n = 70) of
swimming trials
performed
Unknown total number of
swimmers and time trials.










35 males aged 18–19
performing 5 swimming trials
(2.4–3.6 km) over 2 months
(mid-Jan to mid-Mar). Trials
were ≥ 1 week apart
Moderately cold open
sea, (16–18 °C), diving
jackets, supine position
with fins
When, in the absence of prior
seawater aspiration, the swimmer









(4.6%), 21 mild cases
(12%) 60% of
swimmers (n = 21)
had 29 episodes
of SIPE
Sample size small. Study









30 males aged 18–19
performing a single 2.4 km
swimming trial
Warm open sea
(23 °C), no wetsuit, supine
with fins, over- hydration
(trainees drank approx.
5 l of water prior to
swimming)





26.7% (n = 8) of
swimmers in one trial
Only one swimming trial.
No clear case definition







































used for calculating the rate of incidence. For example,
some authors used the total number of swimmers as the
denominator [13, 14], whereas others used the total
number of swims [12, 15, 16].
Quality of Studies
Three studies had a clearly specified and defined popula-
tion of military trainees [12–14]; the remaining two con-
tained no demographic information on the at risk
population except on identified cases [15, 16]. Inclusion
and exclusion criteria were not documented in any of
the studies. SIPE case definitions were mostly clearly
described, although they varied considerably and the de-
nominator used to calculate incidence varied making the
results difficult to compare reliably (see “Search Strat-
egy” section); in none of the studies were the cases cen-
sored in the subsequent analysis (in other words, cases
could be counted more than once). As mentioned earl-
ier, Shupak et al. [13] was the only study that collected
data from all participants rather than just those that
sought medical attention, making it possible to identify
milder cases of SIPE. For full results of the risk of bias
assessment, please see Additional file 4.
Findings
Quantitative synthesis was not possible due to the het-
erogeneous nature of the studies, in particular, the mili-
tary trainees in the three studies in Israel were young
men engaged in rigorous training programmes, whereas
the UK and Swedish studies included recreational swim-
mers of all ages and both sexes. Incidence figures for
SIPE varied from 0.01% of triathlons raced in the UK
study [16], to 0.5% of outdoor swimming races that were
swum in the Swedish study [15], to 1.8%, 16.6% and
26.7% of time trials performed by Israeli military trainees
[12–14] respectively. Of the 29 cases of SIPE recorded
by Shupak et al. [13], 8 were categorised as severe cases
and 21 as mild, which is equivalent to 4.6% and 12.0% of
swimming trials performed respectively.
What Is the Prevalence of Having Experienced SIPE?
Description of Studies
Four cross-sectional surveys were identified; however,
only one was of surface swimmers. This was a large sur-
vey of triathletes in the USA (Table 2) [19]. The
remaining studies were of scuba divers [20] and
breath-hold divers [21, 22], so they were excluded from
the review. Miller et al. [19] distributed a swim-related
breathing problems survey to 140,000 USA Triathlon
members and received 1400 valid responses. The case
definition was limited to a cough productive of pink
frothy or blood-tinged secretions during swimming. In-
formation on the type of exposure was collected, such as
open water versus pool environment, use of a wetsuit,
course length and climate.
Quality of Studies
Miller et al. [19] carried out a large study with a strong
design, providing a detailed description of the sampling
frame and methodology. The demographics of the sam-
ple appeared representative of USA Triathlon members.
The analysis was robust and used appropriate numera-
tors and denominators. However, the response rate was
very low at 1.3% and data were collected through the
use of a non-validated self-completed questionnaire. For
full results of the risk of bias assessment, please see
Additional file 4.
Findings
Miller et al. [19] reported a prevalence of symptoms
consistent with SIPE of 1.4% of triathletes.
What Are the Risk Factors for SIPE?
Description of Studies
Three studies met the inclusion criteria; a case-control
study of triathletes in the USA [19], a cohort study of mili-
tary trainees in Israel [13] and a small clinical trial involv-
ing 10 SIPE susceptible individuals [23] (see Table 3). An
additional six studies that addressed risk factors were
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Table 3 Risk factors associated with SIPE
References Study
design







Exposures investigated Findings Quality of
evidence
(see Additional













































































































































































































identified but were excluded due to not meeting the inclu-
sion criteria, i.e. studies of scuba divers [5, 24], very small
sample sizes [5], the lack of a control or comparator group
[3, 12, 15] or the use of an inappropriate comparator
group3 [25]. Miller et al. [19] used the responses from
their large survey of USA Triathlon members aged ≥ 20
(85% were aged ≥ 30) augmented by 11 cases identified
through slowtwitch.com (an online triathlon discussion
forum), to reach a sample size of 1411 cases. Shupak et al.
[13] studied a cohort of 35 military trainees (males aged
18–19) carrying out swimming time trials over a 2-month
period. Moon et al. [23] studied 30 healthy subjects, of
whom 10 had experienced ≥ 1 episode of SIPE during div-
ing (2 subjects), racing or training for a triathlon (5 sub-
jects), both (2 subjects) or after falling from a windsurfer
(1 subject). Study participants carried out moderate cycle
ergometer exercise for 6 to 7 min whilst submerged in
water of 20 °C. All of the SIPE subjects then repeated the
exercise following an oral dose of 50 mg sildenafil.
Measurements of mean arterial pressure (MAP), mean
pulmonary artery pressure (MPAP) and pulmonary artery
wedge pressure (PAWP) were taken before immersion,
during immersed exercise and shortly afterward. The
types of exposure identified by Miller et al. [19] and Moon
et al. [23] were very varied in terms of personal and envir-
onmental factors, whereas the participants in Shupak et al.
[13] were all swimming in moderately cold open sea (16–
18 °C), wearing diving jackets and fins and swimming in
the supine position. Case definitions in Miller et al. [19]
and Shupak et al. [13] both included a cough; however,
Miller et al. [19] incorporated pink frothy or blood-tinged
secretions, whereas Shupak et al. [13] specified shortness
of breath and lack of aspiration of seawater. Moon et al.
[23] did not report a case definition for SIPE.
Quality of Studies
Miller et al. [19] reported good representation in terms
of age and sex of participants and studied a wide range
of risk factors. Shupak et al. [12] studied only two types
of risk factor: pulmonary function and self-reported level
of exertion, and Moon et al. [23] focussed only on
haemodynamics and gas exchange measurements. A
weakness of Miller et al. [19] and Shupak et al. [13] was
the use of a self-reported non-validated questionnaire to
detect cases of SIPE. Miller et al. [19] included questions
on health conditions such as hypertension and diabetes
in their questionnaire; however, it is not clear when diag-
nosis took place, i.e. before or after SIPE occurred, or if
any medications were being taken. There is some evi-
dence that self-reports may underestimate the preva-
lence of hypertension [26], although some studies have
shown them to be a valid measure [27, 28]. Another
shared weakness of Miller et al. [19] and Shupak et al.
[12] is the lack of statistical power needed to detect
significant relationships and differences between groups,
due to relatively small sample sizes used. For example,
Miller et al. [19] reported odds ratios of > 2 for nine risk
factors; however, p values were low enough in only four
of them to demonstrate statistical significance. Moon et
al. [23] acknowledged that the SIPE group contained a
much higher proportion of females than the control
group and may have been physically fitter. There were
also differences in the exclusion criteria used for select-
ing cases and controls. Additional file 4 shows full re-
sults of the quality assessment.
Findings
The populations studied by Miller et al. [19] and Moon
et al. [23] were much more heterogeneous compared to
Shupak et al. [13], i.e. male and females of varying ages
versus young 18–19-year-old healthy male military re-
cruits on rigorous training programmes. Therefore, we
did not attempt quantitative synthesis. Miller et al. [19]
showed the following risk factors to be associated with
developing SIPE: hypertension, female sex, fish oil use
and long course distance (i.e. ≥ half-ironman distance:
1.9 km swim, 90 km bike ride and 21.1 km run). Shupak
et al. [13] found that lung volumes and mid-expiratory
flow measured 12 months earlier were significantly
lower in those who had experienced SIPE compared to
the asymptomatic group. Shupak et al. [13] also reported
no correlations between level of exertion and occurrence
of SIPE. The results of Moon et al. [23] showed that the
SIPE group had significantly higher MPAP and PAWP
than non-SIPE group during immersed exercise, when
accounting for differences in cardiac output. Tidal vol-
ume was also significantly lower in the SIPE group.
Prognosis
The following research questions regarding prognosis
were addressed:
1. What are the short-term outcomes of SIPE?
2. What is the recurrence rate of SIPE?
3. What are the long-term health sequelae of an
episode of SIPE?
We considered short-term outcomes to be those that
occurred < 30 days after an episode of SIPE, such as re-
covery time, hospitalisation and death. Long-term health
sequelae were considered to be those which occurred ≥
30 days following an episode.
Description of Studies
Five studies met the inclusion criteria; three of Israeli
military trainees [12–14] (described in “What is the inci-
dence of SIPE?” section), one of US Navy Special War-
fare personnel [29] and one of outdoor swimmers in
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Table 4 Prognosis of SIPE
















































































































































































































































































Table 4 Prognosis of SIPE (Continued)

























































































































































Sweden [15] (described in “What is the incidence of
SIPE?” section). Ludwig et al. [29] studied a group of 20
males aged 19–36, 11 of whom had recovered from an
episode of SIPE 4–14 weeks before the study com-
menced. Case definitions are described in Table 4. Lud-
wig et al. [29] had much more rigorous requirements for
a diagnosis to be made compared to the other studies
(see Table 4). In all studies, SIPE cases were ascertained
through swimmers receiving medical attention, apart
from Shupak et al. [13] who required all trainees to
complete post-swim questionnaires.
Only three studies reported short-term outcomes such
as recovery time [12, 14, 15] and hospitalisation [14] and
we found no studies that reported any deaths following
SIPE. Adir et al. [12] carried out chest radiographs 12–
18 h after the onset of SIPE symptoms. They also per-
formed spirometry on a subsample of 37 trainees 6–12 h
and 1 week after diagnosis of SIPE, and compared find-
ings with baseline measurements.
Four studies provided data on recurrences, however,
this was reported in different ways: Adir et al. [12] and
Shupak et al. [13] reported recurrences of SIPE episodes
that occurred during the study period (i.e. 3 years and
2 months respectively), whereas Weiler-Ravell et al. [14]
reported recurrences that took place at unspecified times
later within the same training programme, but outside
the study period. Braman Eriksson et al. [15] asked par-
ticipants to report their previous experience of respira-
tory distress whilst swimming.
Longer-term outcomes were studied only in one study:
the SIPE subjects studied by Ludwig et al. [29] had all
fully recovered from SIPE at least 1 month before enrol-
ment in the study. This examined cardiopulmonary
function (exercise tolerance, lung volumes and flows,
pulmonary artery pressure response to hypoxaemia) at
4–14 weeks after SIPE.
Quality of Studies
Most of the studies were not designed as prognosis
studies, and it was difficult to make comparisons be-
tween them because of differences in the outcomes
described and the way in which they were reported.
Apart from Braman Eriksson et al. [15], the charac-
teristics of study participants were clearly defined in
all prognosis studies. Although the sample sizes were
small in the three studies of Israeli military trainees,
they are likely to be representative of the military
population in terms of age and sex. The representa-
tiveness of the participants of Ludwig et al. [29] and
Braman Eriksson et al. [15] is unclear as no demo-
graphic information on the at risk populations were
reported. For full results of our critical appraisal of
these studies, please see Additional file 4.
Findings
The three studies that reported recovery time following
SIPE found that all affected swimmers recovered from
SIPE symptoms within 24 h [12, 14, 15]. Adir et al. [12]
reported that chest radiographs were all normal in the
first 24 h; however, the subsample of 37 trainees who
had spirometry showed reduced lung volumes that per-
sisted for a week. All eight swimmers studied by
Weiler-Ravell et al. [14] that were suffering from SIPE
were admitted to hospital overnight.
Reported recurrence rates in affected military trainees
were 23% within 3–36 months after their first episode in
one study [12], and 25% at an unspecified time during
the remainder of the training programme in another
[14]. The proportion of episodes of SIPE that were re-
currences was 31% in two studies: in one, the previous
episodes were documented [13] and in the other, the
participants reported having previous experienced re-
spiratory difficulties whilst swimming [15].
In their study of longer-term outcomes, Ludwig et al.
[29] found no significant differences in cardiopulmonary
function between SIPE patients and controls 4–14 weeks
after the episode.
What Is the Evidence of the Effectiveness of Interventions
for Preventing a Recurrence of SIPE?
Description of Studies
Only two relevant studies were found; a small clinical
trial [23] and a single case report [30]. Both studies ex-
amined the effect of the drug sildenafil on MAP, MPAP
and PAWP. A description of the clinical trial [23] is in-
cluded in “What are the risk factors for SIPE?” section.
Moon et al. [23] compared outcomes before and after
sildenafil in the SIPE participants. The second study was
of a 46-year-old elite female ultra-triathlete who had suf-
fered ≥ 5 episodes of SIPE [30]. The subject exercised for
6 min in 19 °C water, before and after a 50 mg oral dose
of sildenafil. Measurements of MAP, MPAP and PAWP
were taken at rest in dry conditions, and during
immersed exercise both before and after sildenafil was
administered. The woman also reported taking sildenafil
before triathlons over the next 5 years and reported
whether SIPE occurred.
Quality of Studies
Both studies were small and did not include an un-
treated control group with a history of SIPE. The clinical
trial did not report any clinical outcomes and the inter-
vention did not take place in “real-world” conditions. As
studies of effectiveness, then, they were of low quality. A
strength of the case report was that the study participant
reported clinical outcomes, i.e. recurrences of SIPE over
the following 5 years having taken sildenafil before tri-
athlon events.
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Findings
Moon et al. [23] found that before taking sildenafil, both
MPAP and PAWP were higher during exercise in cold
water in SIPE subjects, compared to non-SIPE subjects.
After taking sildenafil, MPAP and PAWP of SIPE sub-
jects was reduced to a level similar to that of the
non-SIPE subjects. In their case report, Martina et al.
[30] showed a similar effect of sildenafil in that MPAP
and PAWP were lower with sildenafil than without. Fol-
lowing the study, the subject took sildenafil before 20




We did not find conclusive evidence on the risk of de-
veloping SIPE for open water swimmers because the
relevant studies differed greatly from each other in case
definition, swimming environment, population charac-
teristics and denominators [12–16, 19]. However, SIPE
appears to occur in approximately 1.4% of triathletes.
It seems likely that hypertension, taking fish oil sup-
plements and long course triathlon distance are risk fac-
tors for developing SIPE, as are non-modifiable factors
such as female sex, lower lung volumes and flows, higher
pulmonary artery and pulmonary artery wedge pres-
sures, and lower tidal volumes during exercise in cold
water [13, 19, 23]. However, the evidence for each risk
factor comes from only one study.
The evidence suggests that SIPE symptoms normally
resolve quickly following an episode [12, 14, 15]. How-
ever, we did not find any studies that reported deaths
from SIPE. This may be due to difficulties differentiating
between SIPE-related deaths and those caused by
drowning for other reasons [4]. Three studies that re-
ported short-term outcomes suggest that hospitalisation
is not a common occurrence with 5% of cases being ad-
mitted [12, 14, 15]. Studies suggest that recurrences are
common, although it is difficult to be sure of the size of
the problem as the studies were in general not designed
to quantify this [12–15]. One small study observed re-
strictive lung function defects that persisted for a week
following SIPE [12]. The single small study of the
long-term effects of SIPE on cardiopulmonary function
only had a follow-up period of up to 14 weeks; it found
no significant effects [29]. We found no studies of se-
quelae after 3 months. We found no conclusive evidence
that sildenafil can prevent recurrences, although the
studies’ results suggest that it would be appropriate to
investigate this drug further for this indication [23, 30].
Strengths and Weaknesses of the Review
To our knowledge, this is the first systematic review to
gather together all the available epidemiological evidence
on SIPE occurrence, risk factors, prognosis and interven-
tions to prevent recurrences. However, our research was
limited by the small number of well-designed studies
that have been published. Our search strategy and inclu-
sion criteria were broad to avoid omitting any potentially
relevant publications. Our decision to exclude studies of
IPE in scuba divers and breath-hold divers as well as sin-
gle case reports4 and smaller case series/case control
studies may have created a selection bias in favour of
studies of young military trainees who are not represen-
tative of the general population of surface swimmers and
triathletes. The exclusion of risk factor studies without
an asymptomatic comparator group meant that very few
risk factor studies met the inclusion criteria.
Strengths and Weaknesses of the Available Evidence
Five studies reported greatly varying figures for the inci-
dence of SIPE. This variation may be explained by differ-
ences between the studies in swimming environment
(e.g. fresh or sea water; water temperature; nature of
competition—recreational or military, for example),
study participant characteristics, study length and dur-
ation of follow up, case definition and ascertainment
methods, time to follow-up and methods of analysis.
None of the incidence studies censored participants who
had developed SIPE. Incidence rates were reported in
different ways depending on whether the denominator
was the number of swims or swimmers. Shupak et al.
[13] distinguished between severe and mild cases of SIPE
by collecting data on all participants, rather than just
those that were seen by a clinician. This suggests that
the other incidence figures reported [12, 14–16] may be
underestimates. The prevalence study of USA Triathlon
members [19], while fairly representative, was limited by
the use of a self-completed non-validated questionnaire,
a narrow case definition and a very low response rate.
Two of the risk factor studies were limited by the use
of self-reported non-validated questionnaires to detect
cases of SIPE and may have lacked statistical power due
to the small number of SIPE cases included [13, 19].
This low statistical power meant that Miller et al. [19]
were not able to demonstrate statistical significance for
risk factors where odds ratios were > 2, such as age 50–
59, taking vitamin C and pre-swim hydration of more
than 1 l. It is also unclear if the health conditions re-
ported by Miller et al. [19] were diagnosed before or
after SIPE, or if individuals had taken medication. The
third risk factor study was a small clinical trial where
participants were not randomly selected and characteris-
tics of cases and controls differed [23].
Most of the prognosis studies were not designed as
such and were heterogeneous, using different case defi-
nitions, outcomes and follow-up periods [12–15, 29].
The representativeness of participants is also unclear.
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Our findings in relation to early recovery correspond
with those of a recent summary of published case re-
ports in which symptoms resolved within 48 h in 31 out
of 38 reports (the symptoms persisting after 48 h in 7
non-resolved cases were not described) [31]. Adir et al.
[12] suggested their findings of restrictive lung function
deficit that persisted for a week following SIPE may indi-
cate persistent pulmonary oedema and damage to capil-
laries; however, no symptoms and/or spirometric
outcomes after this period were reported by the authors,
so it is unclear how long the lung function deficit lasted
or whether the participants had any clinical problems.
We found no studies reporting deaths of swimmers
resulting from SIPE. Peacher et al. [3], in a review of
published case reports, identified six published reports
of deaths from IPE, but only in scuba divers. Deaths
from SIPE in surface swimmers may be underestimated,
especially those occurring during unsupervised training
sessions in open water, which may be attributed simply
to drowning. There is no separate ICD-10 code to iden-
tify death from SIPE. Harris et al. [32] studied 2971 USA
Triathlon events from January 2006 to September 2008
and discovered 13 swim-related deaths that occurred
during 13 triathlons; drowning was declared the cause of
death for each one. In a study of 135 deaths and cardiac
arrests in US triathlon participants between 1985 and
2016, Harris et al. [33] discovered 85 deaths that oc-
curred during the swim phase. This accounted for 70%
of all triathlon deaths; however, the individual causes of
death were not reported for these particular cases.
Information on the long-term effects of SIPE is lack-
ing. The single, very small, relevant study only studied
patients up to 14 weeks after recovery from SIPE and
did not ask the patients about their symptoms, focusing
only on measures of cardiopulmonary function [29]. The
findings of a study of scuba divers showed a similar re-
sult; 6 months after admission for IPE, respiratory func-
tion, cardiac echography and exercise tolerance tests
were all normal [34]. However, this study also did not
report symptoms, which may be present despite un-
detectable changes in investigations.
The studies suggest that recurrence of SIPE is common,
although the different study designs used make it difficult
to assess the accuracy and precision of the findings.
Two intervention studies suggested that sildenafil may
be useful as a treatment to help reduce the risk of recur-
rence of SIPE in susceptible individuals, but the evidence
is inconclusive. Neither was controlled by including an
untreated control group with a history of SIPE, nor re-
ported any clinical outcomes.
Risk Factor Mechanisms
There has been much discussion on the mechanisms
which lead to an increased risk of SIPE. The association
between hypertension and IPE has been widely consid-
ered [3, 24, 35]. Hypertension can lead to diastolic dys-
function which is thought to increase the pressure in the
pulmonary capillaries resulting in fluid leaking into the
alveoli [2]. Wilmshurst et al. [24] found that blood pres-
sure in a group of 11 SIPE susceptible divers became sig-
nificantly higher than the control group following
exposure to cold and/or raised partial pressure of oxy-
gen. Peacher et al. [3] carried out a literature review of
292 cases of pulmonary oedema in swimmers and divers,
as well as a case series study (n = 36). They found that
16% of the recreational swimmers and divers were re-
ported to have hypertension, as were 17% of cases in
their case series. Gempp et al. [35] found that 23% of
the 73 scuba divers treated for IPE at a French hyper-
baric facility suffered from hypertension. However, these
hypertension prevalence figures for IPE cases reported
by Peacher et al. [3] and Gempp et al. [35] are lower
than World Health Organisation region crude estimates
(Europe: 28.1%, Americas: 18.8%, Eastern Mediterra-
nean: 22.0%) [36], so do not show a clear link between
hypertension and IPE.
The connection between SIPE and fish oil consump-
tion is believed to be caused by its anti-platelet and
vasodilatory effect which can make it easier for fluid to
pass into the pulmonary capillaries [19]. The use of the
anti-platelet medication aspirin in breath-hold divers has
also been linked to three cases of SIPE in a small case
series [37]. Miller et al. [19] suggested that the relation-
ship between long course distance and SIPE may be re-
lated to wetsuit use, as the authors were unable to
separate the effects of these two factors. The relationship
between IPE and female sex was discussed by Coulange
et al. [34] who reported a statistically higher incidence of
pulmonary oedema in female scuba divers. Guenette et
al. [38] tested the response to exercise of endurance
trained athletes and found there were disadvantages in
pulmonary response to exercise of females that was
probably due to lung size. Hopkins et al. [39] suggested
smaller lung size might be the mechanism by which
females are at a higher risk of pulmonary oedema. The
findings of Shupak et al. [13] that affected military
trainees had significantly smaller initial lung volumes
and flows suggests that even in males, smaller lung vol-
umes may lead to a greater risk of SIPE. In a study of a
small number of SIPE and high-altitude pulmonary
oedema (HAPE) subjects and controls, Carter et al. [40]
found no significant difference in lung volumes; how-
ever, the SIPE/HAPE subjects did have a lower lung
density and mass, and fewer pulmonary lymphatics. The
authors hypothesised that a limited pulmonary lymph-
atic system was less able to reabsorb excess fluid that
leaked into the interstitial and alveolar space, leading to
a greater risk of pulmonary oedema.
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Recommendations for Future Research
Future studies of the frequency of SIPE should focus on
those with milder symptoms in order to reflect the true
burden of this condition. Larger studies that can repli-
cate the findings on hypertension, fish oil consump-
tion, long course distance, lower lung volumes and
flows, higher pulmonary artery pressures and pulmon-
ary artery wedge pressures and lower tidal volumes
during exercise in cold water, as risk factors for SIPE,
are needed to improve our understanding of SIPE.
Future research should explore other proposed risk
factors such as wetsuit use, age, over hydration, water
temperature, swimming position, exertion, presence of
specific genes variants, failure to warm up and varia-
tions in stress response. Future studies must also
examine the effects of SIPE on the cardiorespiratory
system over the months and years after the initial or
repeated episode, including studies of symptoms as
well as cardiovascular and respiratory function tests.
Sildenafil has showed promise as a potential prophy-
lactic against SIPE; the drug now needs to undergo
randomised controlled trials to determine its efficacy.
Conclusions
The evidence on the occurrence of SIPE suggests that it
is an important public health issue for recreational en-
durance open water swimmers, clinicians and event or-
ganisers, which is particularly important given the
popularity of this sport in the UK and other countries. It
is likely that current estimates are underestimates of the
true burden of this condition. It appears that recurrence
rates are high, so it is important to advise SIPE patients
of this and recommend close supervision by others who
can help them get out of the water if affected.
Endnotes
1The Rubicon Foundation is a non-profit organisation
interested in research, exploration, science and educa-
tion which hosts a digital repository of diving and envir-
onmental physiology research.
2Rebreathers absorb the carbon dioxide exhaled by a
diver whilst recycling the unused oxygen content and
replenishing it for the next breath.
3Participants of the 1985 to 1995 Hawaii Ironman
World Championships were deemed unrepresentative of
the overall triathlete population.
4Case reports were included in the section addressing
interventions to prevent SIPE recurrences due to the
very limited amount of relevant literature
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